These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17505515)

  • 21. Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance.
    Lasorella A; Iavarone A; Israel MA
    Cancer Res; 1995 Oct; 55(20):4711-6. PubMed ID: 7553653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.
    Poljakova J; Hrebackova J; Dvorakova M; Moserova M; Eckschlager T; Hrabeta J; Göttlicherova M; Kopejtkova B; Frei E; Kizek R; Stiborova M
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():101-16. PubMed ID: 22167207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines.
    Michaelis M; Kleinschmidt MC; Barth S; Rothweiler F; Geiler J; Breitling R; Mayer B; Deubzer H; Witt O; Kreuter J; Doerr HW; Cinatl J; Cinatl J
    Biochem Pharmacol; 2010 Jan; 79(2):130-6. PubMed ID: 19698702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic Signature of Neuroblastoma Cells UKF-NB-4 Reveals Key Role of Lysosomal Sequestration and the Proteasome Complex in Acquiring Chemoresistance to Cisplatin.
    Merlos Rodrigo MA; Buchtelova H; de Los Rios V; Casal JI; Eckschlager T; Hrabeta J; Belhajova M; Heger Z; Adam V
    J Proteome Res; 2019 Mar; 18(3):1255-1263. PubMed ID: 30592607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gamma linolenic acid alters the cytotoxic activity of anticancer drugs on cultured human neuroblastoma cells.
    Ikushima S; Fujiwara F; Todo S; Imashuku S
    Anticancer Res; 1990; 10(4):1055-9. PubMed ID: 2166461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells.
    Czaplinski S; Abhari BA; Torkov A; Seggewiß D; Hugle M; Fulda S
    Oncotarget; 2015 Dec; 6(39):41522-34. PubMed ID: 26575016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptomic Landscape of Cisplatin-Resistant Neuroblastoma Cells.
    Rodrigo MAM; Buchtelova H; Jimenez AMJ; Adam P; Babula P; Heger Z; Adam V
    Cells; 2019 Mar; 8(3):. PubMed ID: 30871063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VPA does not enhance platinum binding to DNA in cisplatin-resistant neuroblastoma cancer cells.
    Raudenska M; Krejcova L; Richtera L; Heger Z; Hrabeta J; Eckschlager T; Stiborova M; Adam V; Kratochvilova M; Masarik M; Gumulec J
    Tumour Biol; 2017 Sep; 39(9):1010428317711656. PubMed ID: 28945187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of peroxisome proliferator-activated receptor delta activity affects neural cell adhesion molecule and polysialyltransferase ST8SiaIV induction by teratogenic valproic acid analogs in F9 cell differentiation.
    Lampen A; Grimaldi PA; Nau H
    Mol Pharmacol; 2005 Jul; 68(1):193-203. PubMed ID: 15829700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers.
    Prochazka P; Hrabeta J; Vicha A; Cipro S; Stejskalova E; Musil Z; Vodicka P; Eckschlager T
    Oncol Rep; 2013 Jun; 29(6):2415-21. PubMed ID: 23563570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of polyunsaturated fatty acids on vincristine-resistance in human neuroblastoma cells.
    Ikushima S; Fujiwara F; Todo S; Imashuku S
    Anticancer Res; 1991; 11(3):1215-20. PubMed ID: 1888152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxicity of L-cycloserine against human neuroblastoma and medulloblastoma cells is associated with the suppression of ganglioside expression.
    Cinatl J; Cinatl J; Kotchetkov R; Pouckova P; Vogel JU; Rabenau H; Michaelis M; Kornhuber B
    Anticancer Res; 1999; 19(6B):5349-54. PubMed ID: 10697560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Over-expression of transfected N-myc oncogene in human SKNSH neuroblastoma cells down-regulates expression of beta 1 integrin subunit.
    Judware R; Culp LA
    Oncogene; 1995 Dec; 11(12):2599-607. PubMed ID: 8545117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of DNA methyltransferase reverses cisplatin induced drug resistance in murine neuroblastoma cells.
    Qiu YY; Mirkin BL; Dwivedi RS
    Cancer Detect Prev; 2005; 29(5):456-63. PubMed ID: 16185816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells.
    Poljaková J; Eckschlager T; Hrabeta J; Hrebacková J; Smutný S; Frei E; Martínek V; Kizek R; Stiborová M
    Biochem Pharmacol; 2009 May; 77(9):1466-79. PubMed ID: 19426684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma.
    Noborio-Hatano K; Kikuchi J; Takatoku M; Shimizu R; Wada T; Ueda M; Nobuyoshi M; Oh I; Sato K; Suzuki T; Ozaki K; Mori M; Nagai T; Muroi K; Kano Y; Furukawa Y; Ozawa K
    Oncogene; 2009 Jan; 28(2):231-42. PubMed ID: 18850009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity of sodium valproate in cultures of human neuroblastoma cells.
    Cinatl J; Cinatl J; Scholz M; Driever PH; Henrich D; Kabickova H; Vogel JU; Doerr HW; Kornhuber B
    Anticancer Drugs; 1996 Sep; 7(7):766-73. PubMed ID: 8949988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
    Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.
    Yan XD; Li M; Yuan Y; Mao N; Pan LY
    Oncol Rep; 2007 May; 17(5):1163-9. PubMed ID: 17390060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.